The biopharma company has taken its overall funding past the $60m mark, with participation from pharmaceutical corporations Pfizer, Novo and GlaxoSmithKline.

News provider CB Insights said, apart from Kaiser Permanente Ventures, the other investors in the round were venture capital firms

Mitsui Ventures - the investment wing of the centuries-old Tokyo conglomerate - led a $14m extended Series C round of funding for GMZ with the new backer providing a further $4.5m.

BASF's Biorenewable subsidiary led the round with its $30m investment in Renmatix, formerly known as Sriya Innovations.

The biofuel company has brought its series C round a year ahead of schedule with energy companies BP, General Electric and ConocoPhillips joining J.F. Shea and Google in financing the round.

The US-based heat to electricity conversion company has also secured backing from BP Alternative Energy and corporate-backed Energy Technology Ventures.

The alternative energy company has raised $25m in a series C round featuring existing investor Total.

The UK-listed telecoms company leads a $9.2m round in the Israel-based fuel cell developer .

Venture arm of Reed Elsevier helps high end advertising firm raise $13m.

IntegenX, which specialises in the use of DNA for human identification, raises $40m in a series C round financed by backers including Samsung and In-Q-Tel.